ATN1 Antibody - N-terminal region : FITC (ARP34153_P050-FITC)

Dentatorubral pallidoluysian atrophy is a rare neurodegenerative disorder characterized by cerebellar ataxia, myoclonic epilepsy, choreoathetosis, and dementia. The disorder is related to the expansion of a trinucleotide repeat within ATN1. The protein includes a serine repeat and a region of alternating acidic and basic amino acids, as well as the variable glutamine repeat. Alternative splicing results in two transcripts variants that encode the same protein.Dentatorubral pallidoluysian atrophy is a rare neurodegenerative disorder characterized by cerebellar ataxia, myoclonic epilepsy, choreoathetosis, and dementia. The disorder is related to the expansion of a trinucleotide repeat within this gene. The encoded protein includes a serine repeat and a region of alternating acidic and basic amino acids, as well as the variable glutamine repeat. Alternative splicing results in two transcripts variants that encode the same protein.

WWOX; Dlg4; SIAH1; HINFP; LRP2; RBFOX1; EFEMP2; NOC2L; RCHY1; ZMYND8; RBFOX2; KAT6B; SSPO; RAD54L2; ZSWIM8; WDR5; WWP2; WWP1; RBPMS; SPAG5; FBLN5; BAIAP2; PSME3; CBFA2T2; CHRD; NCK2; LTBP4; RBM10; KAT6A; BAG6; PRRC2A; TRIP6; TEP1; SLIT1; SIAH2; PSMA3; PLS

All conjugated antibodies should be stored in light-protected vials or covered with a light protecting material (i.e. aluminum foil) . Conjugated antibodies are stable for at least 12 months at 4C. If longer storage is desired (24 months), conjugates may be diluted with up to 50% glycerol and stored at -20C to -80C. Freezing and thawing conjugated antibodies will compromise enzyme activity as well as antibody binding.